$PHBI, Pharmagreen Biotech Inc., is committed to keeping our shareholders and stakeholders informed about our development progress. At the request of the parties involved, we are currently unable to disclose specific details regarding an ongoing transaction to ensure its successful completion. We will provide comprehensive information as soon as concrete details become available.
As announced on Monday, the first LOI is signed, and the second LOI is set to be executed next week. Together, they represent a major step forward for $PHBI. A PR will follow, detailing the 30,000 sq ft state-of-the-art hydroponic indoor cultivation facility and the transgenic plants Pharmagreen plans to produce. Exciting developments ahead for $PHBI
$PHBI Pharmagreen Biotech Inc. is excited to announce the signing of its first LOI for a lease-to-own state-of-the-art, 29,580 sq. ft., EU-GMP-ready facility. This milestone positions us to cultivate transgenic plants and manufacture products, leveraging our expertise to drive revenue and growth. Stay tuned for more updates as we progress!
π¨ Update on $PHBI π¨ Pharmagreen Biotech Inc. is actively negotiating a potential major transaction. With many moving parts involved, we're working diligently to navigate the process and complete it in a timely manner. Stay tuned for more updates! #PHBI#Biotech#Growth
Reminder: $PHBI Pharmagreen Biotech Inc., X spaces tonight 4PM PST / 7PM EST. I look forward to having everyone there and answer any questions. https://t.co/4HmmVYmjh6
$PHBI Pharmagreen Biotech Inc., I will be hosting an X spaces this Friday, January 24th, at 7PM EST. Detailing developments and road map. Press releases will follow.
$PHBI is a great company I am proud to say and lead. I truly believe our focus is of great value not only in business development but also for mankind. I will explain very soon.
$PHBI Pharmagreen Biotech Inc., meetings all day ! Today I can't explain but in the coming days I will. To explain everything a PR will be released and Spaces time and date will be announced, all interested are welcome and encouraged to attend. Stay tuned.
2025 is shaping up to be an exciting and transformative year for OTC Markets companies, particularly for those that demonstrate a commitment to excellence and put in the hard work to achieve success. With evolving market dynamics, increasing investor interest, and new opportunities for growth and innovation, companies that stay focused, adaptable, and driven are well-positioned to capitalize on these trends and make significant strides toward their goals. IE: $PHBI
$PHBI Thanksgiving Greetings
Pharmagreen Biotech Inc. extends heartfelt Thanksgiving wishes to everyone, hoping you enjoy this special time surrounded by friends and family. Weβre thrilled to share that exciting developments are on the horizon! While mergers and acquisitions take time, the management team remains fully committed to enhancing shareholder value β a priority I personally share as a shareholder myself. As part of my dedication to our growth, I will again personally cover OTC fees and accounting expenses to ensure the company steers clear of toxic financing.
πΏ $PHBI, Pharmagreen Biotech Inc. unveils a short video exploring 'Live Rosin' and its vast potential in the expanding EU cannabis market! πβ¨ With cannabis decriminalized in many EU nations for medicinal use and some countries, like Germany, paving the way for recreational sales, the opportunities are immense. Stay tuned for insights on how Pharmagreen is positioning itself to be a part of this dynamic industry. π #LiveRosin #CannabisInnovation #PHBI #EUMarket
$PHBI, Pharmagreen Biotech Inc. is steadfast in its efforts to secure the required licenses for the production and export of its premium Live Rosin product. To establish an immediate foothold in the rapidly expanding EU market, the company is actively pursuing a strategic merger or acquisition of a cGMP-certified facility within the region. This initiative underscores Pharmagreen's focus to establish market entry for distribution and its own brand development.
$PHBI, Pharmagreen Biotech Inc. is making steady progress in its ongoing collaboration with government representatives. While working with a government is a long-term process that was initiated some time ago, we recognize there is still much work ahead. We remain committed to navigating this journey and advancing our business development efforts step by step. #Pharmagreen #BusinessDevelopment #Innovation
$PHBI, and its management, wishing everyone a wonderful weekend filled with family and warmth as we celebrate Thanksgiving here in Canada and Indigenous Peoples' Day in the U.S. My heartfelt thoughts are with those recovering from the recent hurricanes down South. Take care, stay safe, and be well.